Increased expression of NKCC1 protein and its elevated phosphorylation, with a concurrent increase in the phosphorylation of serine–threonine kinases WNK, in TMZ-treated glioblastoma was reported [24,50,51]. This evidence concerns the gene SLC12A2 and glioblastoma.